辉瑞 CEO：到 2025 年计划在华提交 12 款创新药上市申请

Wallstreetcn
2023.03.25 05:03
3 月 25 日，在中国发展高层论坛 2023 年年会论坛上，辉瑞公司董事长、首席执行官艾伯乐表示，2022 年，辉瑞有 11 个新产品和新适应症获批上市，从现在起到 2025 年，辉瑞计划在华提交约 12 款创新药物的上市申请。（澎湃新闻）
Source: Wallstreetcn The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.